Why Pheochromocytoma Causes Weight Loss and Constipation
Pheochromocytoma causes weight loss through catecholamine-induced hypermetabolism that increases resting energy expenditure by approximately 10%, and causes constipation through excessive norepinephrine's inhibitory effects on intestinal motility via alpha-adrenergic receptor activation.
Mechanism of Weight Loss
The weight loss in pheochromocytoma results from chronic catecholamine excess creating a hypermetabolic state 1. Research demonstrates that patients with pheochromocytoma have resting energy expenditure (REE) that is 10.4% higher than predicted values (1731 vs 1581 kcal/day), despite normal food intake 2. This occurs because:
- Norepinephrine and normetanephrine directly correlate with increased metabolic rate - these specific catecholamines show the strongest negative correlation with body weight 3
- The chronic catecholamine overproduction induces a proinflammatory state with elevated TNF-α, IL-6, and IL-8, contributing to the hypermetabolic condition 2
- After surgical removal, REE significantly decreases and patients typically gain weight, with body mass index increasing proportionally 2, 4
The weight loss is most pronounced in patients with high preoperative urinary normetanephrine levels 4. Persistently elevated catecholamines with decreasing weight indicate metastatic or recurrent disease 3.
Mechanism of Constipation
Constipation occurs in approximately 6% of pheochromocytoma patients and represents a potentially lethal complication 5. The pathophysiology involves:
- Excessive norepinephrine inhibits intestinal motility through alpha-adrenergic receptor stimulation, causing intestinal pseudo-obstruction 6, 5
- Constipation is specifically associated with excessive noradrenaline production (P<0.0001) 5
- The condition typically occurs with large primary tumors (>5 cm) or extensive metastases 5
Clinical Significance and Management
Severe constipation can progress to toxic megacolon and sepsis, which has caused death in reported cases 5. The condition improves dramatically after tumor resection in non-metastatic cases 6, 5.
For symptomatic management before surgery:
- Systematic combination of fiber, water, and laxatives effectively improves symptoms 5
- Anti-cholinergic agents may benefit acute colonic pseudo-obstruction 7
- Avoid dopamine antagonists (metoclopramide) and high-dose corticosteroids unless adequate alpha-blockade is established, as these can precipitate catecholaminergic crisis 7
Associated Clinical Features
Both weight loss and constipation typically occur alongside the classic triad of headaches, palpitations, and diaphoresis 1, 5. The presence of constipation as a presenting symptom should prompt evaluation for weight loss and excessive norepinephrine production, as these features cluster together 5.
Important caveat: Some patients present with atypical manifestations - constipation, intestinal pseudo-obstruction, and weight loss - without the typical hypertension or tachycardia 6. This can delay diagnosis, making it crucial to maintain clinical suspicion even when classic cardiovascular symptoms are absent.